Mauna Kea Technologies SA (EPA: ALMKT)
France
· Delayed Price · Currency is EUR 0.178
+0.005 (3.12%)
Jan 17, 2025, 5:35 PM CET
Mauna Kea Technologies Revenue
Mauna Kea Technologies had revenue of 4.27M EUR in the half year ending June 30, 2024, with 15.13% growth. This brings the company's revenue in the last twelve months to 8.16M, down -29.35% year-over-year. In the year 2023, Mauna Kea Technologies had annual revenue of 11.03M with 35.97% growth.
Revenue (ttm)
8.16M
Revenue Growth
-29.35%
P/S Ratio
1.12
Revenue / Employee
125.46K
Employees
68
Market Cap
11.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 11.03M | 2.92M | 35.97% |
| Dec 31, 2022 | 8.11M | -429.00K | -5.02% |
| Dec 31, 2021 | 8.54M | 1.29M | 17.75% |
| Dec 31, 2020 | 7.25M | -1.26M | -14.77% |
| Dec 31, 2019 | 8.51M | 608.00K | 7.70% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech | 2.74B |
| bioMérieux | 3.81B |
| Ipsen | 3.44B |
| Eurofins Scientific SE | 6.72B |
| Virbac | 1.34B |
| Ramsay Générale de Santé | 5.01B |